fluoxymesterone and Local Neoplasm Recurrence
fluoxymesterone has been researched along with Local Neoplasm Recurrence in 10 studies
Research
Studies (10)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (50.00) | 18.7374 |
1990's | 5 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Abrams, J; Aisner, J; Budman, D; Cirrincione, C; Citron, M; Holland, J; Muss, H; Panasci, L; Perloff, M; Perry, M | 1 |
Abeloff, MD; Falkson, G; Falkson, HC; Gilchrist, K; Gray, R; Tormey, DC | 1 |
Abeloff, MD; Cummings, FJ; Falkson, G; Gelman, RS; Osborne, CK; Pandya, KJ; Sledge, GW; Tormey, D | 1 |
Takaya, O | 1 |
Falkson, CI; Falkson, G; Gelman, RS; Glick, J; Harris, J | 1 |
Allen, S; Bosworth, H; Budman, D; Lehrman, D; Lichtman, SM; Schulman, P; Vinciguerra, V; Weiselberg, L; Weiss, R | 1 |
Andersen, JW; Asbury, RF; Benson, AB; Falkson, G; Skeel, RT; Tormey, DC | 1 |
Andersen, J; Poulsen, HS | 1 |
Hashizume, Y; Hirano, M; Ishida, K; Iwa, T; Katada, S; Kawaura, Y; Yamada, T | 1 |
Ehlers, PN | 1 |
Trials
3 trial(s) available for fluoxymesterone and Local Neoplasm Recurrence
Article | Year |
---|---|
Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Regression Analysis; Thiotepa; Treatment Failure; Vinblastine; Vincristine | 1995 |
Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Fluoxymesterone; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Receptors, Estrogen; Survival Rate; Tamoxifen; Thiotepa; Vinblastine | 1993 |
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Fluoxymesterone; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Survival Rate; Tamoxifen | 1998 |
Other Studies
7 other study(ies) available for fluoxymesterone and Local Neoplasm Recurrence
Article | Year |
---|---|
[Clinical effect of fluoxymesterone in the treatment of recurrent and progressive breast neoplasms].
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Neoplasm Recurrence, Local; Time Factors | 1977 |
Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. An Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Methotrexate; Mitolactol; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Remission Induction; Survival Rate; Tamoxifen | 1992 |
Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esthetics; Female; Fluorouracil; Fluoxymesterone; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prednisone; Radiotherapy; Survival Rate; Thiotepa; Vinblastine; Vincristine | 1991 |
Combination chemotherapy of advanced breast cancer. Comparison of dibromodulcitol, doxorubicin, vincristine, and fluoxymesterone to thiotepa, doxorubicin, vinblastine, and fluoxymesterone: an Eastern Cooperative Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Evaluation; Female; Fluoxymesterone; Humans; Leukopenia; Middle Aged; Mitolactol; Neoplasm Recurrence, Local; Nervous System Diseases; Thiotepa; Thrombocytopenia; Vinblastine; Vincristine | 1989 |
Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diethylstilbestrol; Female; Fluoxymesterone; Humans; Immunohistochemistry; Menopause; Middle Aged; Neoplasm Recurrence, Local; Paraffin; Receptors, Estrogen; Survival Analysis; Tamoxifen | 1989 |
[Treatment of chemo-endocrine therapy in recurrent breast cancer].
Topics: Adult; Androstanols; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Female; Fluoxymesterone; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovariectomy; Tamoxifen | 1986 |
[Supplemental hormone treatment of operable breast neoplasms].
Topics: Adrenalectomy; Aged; Androgens; Breast Neoplasms; Female; Fluoxymesterone; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Norethindrone; Ovary; Sex Chromatin; Testosterone | 1970 |